Replies to post #35763 on NorthWest Biotherapeutics Inc (NWBO)

[TC_Trader]

I believe it's a combination for sure...that PH3 for -L is nearing completion (probably in about a year) and Woodford. Institutional investors are followers and Woodford is a big enough name to be a starter of that trend. They need more though. Hopefully a big name like Baker Brothers jumps in.

I think we'll start seeing some coverage on the buy side before PH3 completes. NWBO has been at this for so long that's why analysts aren't all over it. Now that the light is at the end of the tunnel we should see some action. Summer Street did cover NWBO back in 2013 but they dropped coverage when the analyst left the company. That analyst had a buy rating, started the target at $10.33 and raised it to $15.10.